Hanjo Kim 1 posts 0 comments

Hanjo Kim is the SVP of Global Strategy, Head of Medicinal Chemistry at Standigm, a workflow AI-driven drug discovery company headquartered in Seoul, South Korea with offices in the U.S. and UK. As SVP of Global Strategy, he leads the company’s business development and public relations teams and as Head of Medicinal Chemistry, he leads the medicinal chemist team and the AI scientist team, focusing on organic synthesis-related AI models. This combination of two groups enables the generative models of Standigm to incorporate the patentability, synthetic accessibility, and activity of molecules in its design process. Prior to joining Standigm, he worked as the Principal Researcher, CJ Healthcare R&D Center, Head, EQUIS & ZAROO R&D Center, and Principal Scientist, EQUIS & ZAROO R&D Center. He holds a Ph.D. in organic chemistry from Yonsei University.